Venticute

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2009
01220012009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Respiratory distress syndrome (RDS) is mainly caused by a deficiency of surfactant in structurally immature lungs. Therapy for… (More)
Is this relevant?
2009
2009
Dr. Taut is an employee of Nycomed, the manufacturer of Venticute; Drs. Rippin and Spragg have contractual and consulting… (More)
Is this relevant?
2008
2008
BACKGROUND Studies to date have shown no survival benefit for the use of exogenous surfactant to treat patients with the ARDS. To… (More)
Is this relevant?
2007
2007
BACKGROUND Extensive biochemical and biophysical changes of the pulmonary surfactant system occur in the acute respiratory… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2007
2007
Philipp Markart, Clemens Ruppert, Malgorzata Wygrecka, Thorsten Colaris, Bhola Dahal, Dieter Walmrath, Heinz Harbach, Jochen… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2005
2005
Q: Are we doing any harm by giving antibiotics to the mother in preterm labor or to the preterm baby? Dr. Jobe: I do not think so… (More)
Is this relevant?
2003
2003
We performed a phase I/II trial in North America of a recombinant surfactant protein C-based surfactant (Venticute) as treatment… (More)
  • table 1
  • table 3
  • figure 2
  • figure 3
Is this relevant?
2001
2001
This paper describes a convenient and practice method for quantitation of surfactant phospholipids (1,2-dipalmitoyl-3-sn… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?